Cargando…

A promising connection between BDNF and Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Giuffrida, Maria Laura, Copani, Agata, Rizzarelli, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128436/ https://www.ncbi.nlm.nih.gov/pubmed/30082505 http://dx.doi.org/10.18632/aging.101518

Ejemplares similares

Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type‐1 insulin‐like growth factor receptors in neuronal cells
por: Zimbone, Stefania, et al.
Publicado: (2017)

Role for Metallothionein-3 in the Resistance of Human U87 Glioblastoma Cells to Temozolomide
por: Santangelo, Rosa, et al.
Publicado: (2020)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
por: Giuffrida, Maria Laura
Publicado: (2023)

The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides
por: Naletova, Irina, et al.
Publicado: (2019)

β-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors
por: Santangelo, Rosa, et al.
Publicado: (2021)

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
por: Palasz, Ewelina, et al.
Publicado: (2020)

BDNF and cognitive function in Alzheimer’s disease
por: Sidenkova, A.
Publicado: (2022)

Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons
por: Giuffrida, Maria L., et al.
Publicado: (2015)

The Brain–Liver Connection Between BDNF and Glucose Control
por: Jo, Young-Hwan, et al.
Publicado: (2013)

Polyamine Conjugation as a Promising Strategy To Target Amyloid Aggregation in the Framework of Alzheimer’s Disease
por: Simoni, Elena, et al.
Publicado: (2016)

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2015)

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease
por: Merlo, Sara, et al.
Publicado: (2023)

Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer’s Disease
por: Balietti, Marta, et al.
Publicado: (2017)

Carnosinases, Their Substrates and Diseases
por: Bellia, Francesco, et al.
Publicado: (2014)

Elevation of Peripheral BDNF Promoter Methylation Links to the Risk of Alzheimer's Disease
por: Chang, Lan, et al.
Publicado: (2014)

Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer’s Disease
por: Piancatelli, Daniela, et al.
Publicado: (2022)

BDNF Genotype Modulates Resting Functional Connectivity in Children
por: Thomason, Moriah E., et al.
Publicado: (2009)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

Relationship between BDNF and oxytocin
por: Marazziti, Donatella, et al.
Publicado: (2023)

The promise of music therapy for Alzheimer's disease: A review
por: Matziorinis, Anna Maria, et al.
Publicado: (2022)

Peritoneal signalling improves hippocampal BDNF expression in aged mice
por: Takei, Yoshinori, et al.
Publicado: (2023)

Biosimilars: Promises Made. Promises Kept?
por: Martinez-Cabriales, Sylvia A., et al.
Publicado: (2021)

Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity
por: Angelucci, Francesco, et al.
Publicado: (2023)

Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
por: Lourenco, Mychael V., et al.
Publicado: (2020)

Carnosine, Zinc and Copper: A Menage a Trois in Bone and Cartilage Protection
por: Ciaffaglione, Valeria, et al.
Publicado: (2023)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Evaluation of HIF-1 Involvement in the BDNF and ProBDNF Signaling Pathways among Obstructive Sleep Apnea Patients
por: Gabryelska, Agata, et al.
Publicado: (2022)

What can BDNF genotype tell us about our memory?
por: Diniz, Breno S.
Publicado: (2017)

Experimental status epilepticus, COX‐2 and BDNF: Connecting the dots
por: Marchi, Nicola
Publicado: (2021)

The promise and the challenge of modelling human disease in a dish
por: Gage, Fred
Publicado: (2010)

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
por: Khan, Nazeer Hussain, et al.
Publicado: (2021)

GIRK channels in Alzheimer’s disease
por: Lieberman, Ori J., et al.
Publicado: (2020)

Aptamers: Promising Tools for Cancer Diagnosis and Therapy
por: Cerchia, Laura
Publicado: (2018)

miR-34a: A Promising Target for Inflammaging and Age-Related Diseases
por: Raucci, Angela, et al.
Publicado: (2020)

Ventral tegmental area disruption in Alzheimer’s disease
por: Bozzali, Marco, et al.
Publicado: (2019)

Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model
por: Psotta, Laura, et al.
Publicado: (2015)

Zn(2+) Interaction with Amyloid-B: Affinity and Speciation
por: Arena, Giuseppe, et al.
Publicado: (2019)

Genomic links between blast exposure, brain injury, and Alzheimer disease
por: Conley, Yvette P., et al.
Publicado: (2017)

The promise of stem cells in the therapy of Alzheimer’s disease
por: Yue, Chunmei, et al.
Publicado: (2015)

Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?
por: Fabrizio, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nmo7vveg2g1nroahdp2dllnrml